Intestinal microbiota-kidney cross talk in acute kidney injury and chronic kidney disease

Nephron - Clinical Practice

Volumn 127, Issue 1-4, 2014, Pages 139-143

  Noel, Sanjeev ^a   Martina Lingua, Maria N ^b   Bandapalle, Samatha ^a   Pluznick, Jennifer ^a   Hamad, Abdel Rahim A ^b   Peterson, Daniel A ^b   Rabb, Hamid ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

Acute kidney injury; Chronic kidney disease; Gut; Intestinal microbiota

Indexed keywords

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INTESTINE FLORA; KIDNEY FUNCTION; MICROBIAL DIVERSITY; MICROBIAL IMMUNITY; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; SYMBIOSIS; ACUTE KIDNEY INJURY; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; COMPLICATION; DISEASE COURSE; FORECASTING; GERMFREE ANIMAL; HYGIENE; IMMUNOLOGY; INFLAMMATION; INTESTINE; KIDNEY; LYMPHOCYTE SUBPOPULATION; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; REPERFUSION INJURY; TH1 CELL; VASCULARIZATION;

CYTOKINE; PROBIOTIC AGENT;

ACUTE KIDNEY INJURY; ANIMALS; CYTOKINES; DISEASE PROGRESSION; FORECASTING; GERM-FREE LIFE; HUMANS; HYGIENE; INFLAMMATION; INTESTINES; KIDNEY; LYMPHOCYTE SUBSETS; MICROBIOTA; MODELS, IMMUNOLOGICAL; ORGAN SPECIFICITY; PROBIOTICS; RENAL INSUFFICIENCY, CHRONIC; REPERFUSION INJURY; TH1 CELLS;

EID: 84927737610     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000363209     Document Type: Conference Paper

References (25)

1. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J; Meta-HIT Consortium; Bork P, Ehrlich SD, Wang J: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
2. Bellomo R, Kellum JA, Ronco C: Acute kidney injury. Lancet 2012; 380: 756-766.
3. Wills-Karp M, Santeliz J, Karp CL: The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1: 69-75.
4. Jang HR, Gandolfo MT, Ko GJ, Satpute S, Racusen L, Rabb H: Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury. Am J Physiol Renal Physiol 2009; 297:F1457-F1465.
5. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL: Chronic kidney disease alters intestinal microbial flora. Kidney Int 2013; 83: 308-315.
6. Wang F, Jiang H, Shi K, Ren Y, Zhang P, Cheng S: Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology (Carlton) 2012; 17: 733-738.
7. McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PK: Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 133-141.
8. Maynard CL, Elson CO, Hatton RD, Weaver CT: Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012; 489: 231-241.
9. Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M, Brandi G, Eberl G, Snel J, Kelly D, Cerf-Bensussan N: The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009; 31: 677-689.
10. Wingender G, Stepniak D, Krebs P, Lin L, Mc-Bride S, Wei B, Braun J, Mazmanian SK, Kronenberg M: Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology 2012; 143: 418-428.
11. Nieuwenhuis EE, Matsumoto T, Lindenbergh D, Willemsen R, Kaser A, Simons-Oosterhuis Y, Brugman S, Yamaguchi K, Ishikawa H, Aiba Y, Koga Y, Samsom JN, Oshima K, Kikuchi M, Escher JC, Hattori M, Onderdonk AB, Blumberg RS: Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest 2009; 119: 1241-1250.
12. Macpherson AJ, Harris NL: Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4: 478-485.
13. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK: Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011; 108: 4615-4622.
14. Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan LX, Rey F, Wang T, Firestein SJ, Yanagisawa M, Gordon JI, Eichmann A, Peti-Peterdi J, Caplan MJ: Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci USA 2013; 110: 4410-4415.
15. Peterson DA, Chen Y, Noel S, Bandapalle S, Martina-Lingua MN, White JR, Hamad ARA, Rabb H: Acute kidney injury in mice induces specific changes in gut microbiota. J Am Soc Nephrol 2013; 24: 638A.
16. Fricke WF, Maddox C, Song Y, Bromberg JS: Human microbiota characterization in the course of renal transplantation. Am J Transplant 2014; 14: 416-427.
17. Mafra D, Barros AF, Fouque D: Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients. Future Microbiol 2013; 8: 1317-1323.
18. Anders HJ, Andersen K, Stecher B: The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int 2013; 83: 1010-1016.
19. Ramezani A, Raj DS: The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 2014; 25: 657-670.
20. Soulage CO, Koppe L, Fouque D: Proteinbound uremic toxins: new targets to prevent insulin resistance and dysmetabolism in patients with chronic kidney disease. J Ren Nutr 2013; 23: 464-466.
21. Mafra D, Barros AF, Fouque D: Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients. Future Microbiol 2013; 8: 1317-1323.
22. Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WH, Mullens W: Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol 2013; 62: 485-495.
23. Poesen R, Meijers B, Evenepoel P: The colon: an overlooked site for therapeutics in dialysis patients. Semin Dial 2013; 26: 323-332.
24. Vaziri ND: CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens 2012; 21: 587-592.
25. Ranganathan N, Patel BG, Ranganathan P, Marczely J, Dheer R, Pechenyak B, Dunn SR, Verstraete W, Decroos K, Mehta R, Friedman EA: In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. ASAIO J 2006; 52: 70-79.